Paul Reider - 04 Jan 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Commercial Officer
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Paul Reider
Issuer symbol
CHRS
Transactions as of
04 Jan 2024
Net transactions value
-$6,643
Form type
4
Filing time
08 Jan 2024, 18:58:36 UTC
Previous filing
04 Jan 2024
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $6,643 -2,275 -2.6% $2.92 86,131 04 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.